Patent Assignment
Reel/Frame 029104/0253
Merger
Recorded: 2012-10-10
Pages: 4
Assignor
TRUBION PHARMACEUTICALS, INC.
Executed: 2010-10-28
Assignee
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
2401 FOURTH AVENUE, SUITE 1050, SEATTLE, WASHINGTON, 98121
Covered Property
(1)
Binding Domain-Immunoglobulin Fusion Proteins
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 10, 2012
From: LEDBETTER, JEFFREY A.; HAYDEN-LEDBETTER, MARTHA S.
To: GENECRAFT, INC.
Reel/Frame 029104/0183 →
Change of Name
Oct 10, 2012
From: GENECRAFT, INC.
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 029108/0530 →
Change of Name
Jul 18, 2016
From: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
To: APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 039382/0985 →
Security Interest
Feb 7, 2019
From: APTEVO THERAPEUTICS INC.; APTEVO BIOTHERAPEUTICS INC.; APTEVO RESEARCH AND DEVELOPMENT LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048270/0813 →
Release of Security Interest
Mar 6, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: APTEVO THEAPEUTICS INC.; APTEVO BIOTHERAPEUTICS LLC; APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 052039/0258 →